Type Ii Hypersensitivity
Type II Hypersensitivity is a form of immune-mediated tissue damage characterized by the binding of immunoglobulin G (IgG) or immunoglobulin M (IgM) antibodies to cell-surface antigens, leading to cellular destruction through complement activation, antibody-dependent cellular cytotoxicity, or opsonization.
459
Publications
20K
Citations
2K
Authors
573
Institutions
Publications per year
2017–2026
41
Variants
Cytotoxic Hypersensitivity
Parents
Children
Antigen-antibody Complex FormationAutoimmune ThrombocytopeniaBasement Membrane Antigen TargetingDrug-induced Immune HemolysisFc Receptor-mediated Effector FunctionsHaptens In Drug HypersensitivityIgg-mediated CytotoxicityIgm-mediated CytotoxicityImmune-mediated Cell LysisMaternal-fetal Alloimmune Interactions
459
Jonathan Arnold A. P., I. Bottoli, Andrej Skerjanec et al. · Clinical & Experimental Allergy · 2014 · 241 citations · Full text
1–5 of 459
2K
14
h-index
6
h-index
5
h-index
4
h-index
4
h-index
1–5 of 2K
573

Johns Hopkins University
Baltimore, United States
15 h-index
59 publications
3.4K citations
National Institutes of Health
Bethesda, United States
12 h-index
29 publications
1.5K citations
Inserm
Paris, France
11 h-index
73 publications
4.1K citations

Johns Hopkins Medicine
Baltimore, United States
10 h-index
39 publications
2.2K citations
New York University
New York, United States
9 h-index
22 publications
688 citations
The University of Tokyo
Tokyo, Japan
8 h-index
22 publications
322 citations

Chang Gung University
Taoyuan City, Taiwan
7 h-index
18 publications
1.5K citations
National Institute of Allergy and Infectious Diseases
Bethesda, United States
7 h-index
18 publications
1.3K citations
1–8 of 573
Repository · 83 publications · 3.4K citations
33
h-index
38 publications · 2.6K citations
25
h-index
JI · 29 publications · 1.7K citations
21
h-index
32 publications · 864 citations
17
h-index
13 publications · 737 citations
12
h-index
1–5